IPNA clinical practice recommendations for the management of aHUS and secondary TMA in children

Study limitation reported by the research below: “Anti-FH autoantibody assays lack international standardization, and cut-off values differ across laboratories, which may affect diagnosis and treatment-monitoring decisions globally.”